These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23363829)

  • 21. The Evaluation of the Performance of C. Diff Quik Chek Complete and Toxin A + B (Clostridium difficile) DUO Diagnostic Tests Compared with Toxigenic Culture in the Diagnosis of Clostridium difficile Infection.
    Yazisiz H; Özyurt ÖK; Öngüt G; Baysan BÖ; Dönmez L; Günseren F; Çolak D; Öğünç D
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of
    Senok AC; Aldosari KM; Alowaisheq RA; Abid OA; Alsuhaibani KA; Khan MA; Somily AM
    Saudi J Gastroenterol; 2017; 23(4):259-262. PubMed ID: 28721981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.
    Babady NE; Stiles J; Ruggiero P; Khosa P; Huang D; Shuptar S; Kamboj M; Kiehn TE
    J Clin Microbiol; 2010 Dec; 48(12):4519-24. PubMed ID: 20943860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays.
    Pancholi P; Kelly C; Raczkowski M; Balada-Llasat JM
    J Clin Microbiol; 2012 Apr; 50(4):1331-5. PubMed ID: 22278839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performances of the BD MAX™ CDIFF assay for the detection of toxigenic Clostridioides difficile using Cary-Blair preserved samples.
    Anne-Gaëlle R; Célia S; Jeanne C; Frédéric B; Anne T; Coralie B; Kevin S; Sonia F; Pascaline D; Francois V; Olivier D; Fréderic L
    Diagn Microbiol Infect Dis; 2022 Jul; 103(3):115701. PubMed ID: 35596982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.
    Barkin JA; Nandi N; Miller N; Grace A; Barkin JS; Sussman DA
    Dig Dis Sci; 2012 Oct; 57(10):2592-9. PubMed ID: 22576711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous Detection of
    Yoo IY; Song DJ; Huh HJ; Lee NY
    Ann Lab Med; 2019 Mar; 39(2):214-217. PubMed ID: 30430786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.
    Shin BM; Kuak EY; Lee EJ; Songer JG
    J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory diagnosis of Clostridium difficile infection: Comparison of Techlab C. diff Quik Chek Complete, Xpert C. difficile, and multistep algorithmic approach.
    Seo JY; Jeong JH; Kim KH; Ahn JY; Park PW; Seo YH
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28177534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile testing algorithms using glutamate dehydrogenase antigen and C. difficile toxin enzyme immunoassays with C. difficile nucleic acid amplification testing increase diagnostic yield in a tertiary pediatric population.
    Ota KV; McGowan KL
    J Clin Microbiol; 2012 Apr; 50(4):1185-8. PubMed ID: 22259201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection.
    Kawada M; Annaka M; Kato H; Shibasaki S; Hikosaka K; Mizuno H; Masuda Y; Inamatsu T
    J Infect Chemother; 2011 Dec; 17(6):807-11. PubMed ID: 21725661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive evaluation of chemiluminescent immunoassays for the laboratory diagnosis of Clostridium difficile infection.
    Makristathis A; Zeller I; Mitteregger D; Kundi M; Hirschl AM
    Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1253-1259. PubMed ID: 28181032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between the two-step and the three-step algorithms for the detection of toxigenic Clostridium difficile.
    Qutub MO; AlBaz N; Hawken P; Anoos A
    Indian J Med Microbiol; 2011; 29(3):293-6. PubMed ID: 21860113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory comparison between cell cytotoxicity neutralization assay and ultrasensitive single molecule counting technology for detection of Clostridioides difficile toxins A and B, PCR, enzyme immunoassays, and multistep algorithms.
    Sandlund J; Mills R; Griego-Fullbright C; Wagner A; Estis J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Nolan N; Bishop JJ; Todd J; Young S
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):20-24. PubMed ID: 31129008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective Evaluation of the mariPOC Test for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxins A/B.
    Savolainen R; Koskinen JM; Mentula S; Koskinen JO; Kaukoranta SS
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31941691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study.
    Vogelzang EH; Lankelma JM; van Mansfeld R; van Prehn J; van Houdt R
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1071-1076. PubMed ID: 31970532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of glutamate dehydrogenase (GDH) and toxin A/B rapid tests for Clostridioides (prev. Clostridium) difficile diagnosis in a university hospital in Minas Gerais, Brazil.
    Ramos CP; Lopes EO; Diniz AN; Lobato FCF; Vilela EG; Silva ROS
    Braz J Microbiol; 2020 Sep; 51(3):1139-1143. PubMed ID: 32367261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.
    Deak E; Miller SA; Humphries RM
    J Clin Microbiol; 2014 Mar; 52(3):960-3. PubMed ID: 24352999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New methodological advances: algorithm proposal for management of Clostridium difficile infection].
    González-Abad MJ; Alonso-Sanz M
    Rev Esp Quimioter; 2015 Jun; 28(3):157-9. PubMed ID: 26033001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.